Tokyo, Sept. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059169) titled 'Lung Cancer Genomic Screening Project for Individualized Medicine in Asia' on Sept. 23.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - Lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To elucidate the clinicopathological and molecular biological characteristics of lung cancer with genetic abnormalities and altered protein expression.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 16
years-old
=1500/mm3
ii) Hemoglobin : >=8.0 g/dl
iii) Platelet count : >=7.5 x 104/mm3
iv) AST, ALT : ...